The nation's top medical organization released a major series of papers on medical cannabis last week in the Journal of the American Medical Association, in a move that constitutes a small step for the AMA, but a giant leap in cannabis medical history.
Legalizar el uso medicinal de la marihuana no se traduce en el tan temido aumento de consumo entre adolescentes. Esta es una de las conclusiones de un extenso trabajo que ha analizado datos de 1,1 millones de chavales estadounidenses recabados durante 24 años publicado en The Lancet Psychiatry y que trata de arrojar luz al controvertido debate sobre las consecuencias de la autorización del consumo de cannabis.
La legalización de la marihuana tiene un doble efecto: aumenta la potencia de su mayor principio activo, pero disminuye la presencia de componentes medicinales. Esas son las principales conclusiones de un análisis de la maría que se vende en Colorado (EE UU), donde el consumo y cultivo de esta droga es legal desde el año pasado. Tras el análisis de más de 600 muestras, los químicos de Charas Scientific calcularon que la potencia media de la maría legal de Colorado es de un 18,7%, aunque algunas muestras alcanzaron hasta un 31%, lo que la convierte en la mejor hierba del mundo.
As Obama embarks on the third year of his second term, here are some of the ways in which Obama has begun to deliver on his promises of a more rational, less punitive approach to psychoactive substances. Obama's most significant drug policy accomplishment may be letting states go their own way on marijuana legalization. Even if our next president is a Republican drug warrior, he will have a hard time reversing that decision, especially given the GOP’s lip service to federalism.
The 43-year-old war on drugs had never seen such a barrage of opposition as it did in 2014, with successful marijuana legalization initiatives in several U.S. states, California’s historic approval of sentencing reform for low level drug offenders and world leaders calling for the legal regulation of all drugs — all of which cement the mainstream appeal of drug policy alternatives and offer unprecedented momentum going into 2015.
Ethan Nadelman, director de Drug Policy Alliance, es uno de los expertos más reconocidos en política de drogas a nivel global. Estuvo en Colombia para alimentar el debate sobre la regulación del cannabis medicinal que se abre paso en el Congreso y que será discutido esta semana por el Senado. Nadelmann dice que el cambio de percepción sobre la marihuana recreativa tomó una década en Estados Unidos.
Smoking, growing, buying, selling or merely possessing cannabis is a criminal offence, according to America's federal government. Ask the states, however, and you will get almost 50 different answers. In 13 of them possession of the drug has been decriminalised, meaning that tokers face only minor penalties if caught. In 23 it has been legalised for medical use. And in four—including, following ballot initiatives earlier this month, Alaska and Oregon—cannabis has been legalised outright. In all only 22 states, fewer than half the total, continue to treat the drug as criminal contraband under all circumstances.
A report from Greenwave Advisors, a "comprehensive research and financial analysis for the emerging legalized marijuana industry," projects that legal cannabis could be an industry with revenues of $35 billion by 2020 if marijuana is legalized at the federal level. To put that figure in perspective, $35 billion represents more annual revenue than the NFL (currently $10 billion), and is roughly on par with current revenues for the newspaper publishing industry ($38 billion) and the confectionary industry ($34 billion).
It may be an off-year election, but it's a big one for drug policy reform... voters across the country will have a chance to accelerate the unprecedented momentum to legalize marijuana and end the wider drug war. In fact, there are more drug policy reform questions on the ballot this November than ever in American history. Here is an overview, starting with the highest-profile measures.
As Americans continue to embrace pot—as medicine and for recreational use—opponents are turning to a set of academic researchers to claim that policymakers should avoid relaxing restrictions around marijuana. It's too dangerous, risky, and untested, they say. Just as drug company-funded research has become incredibly controversial in recent years, forcing major medical schools and journals to institute strict disclosure requirements, could there be a conflict of interest issue in the pot debate? (See also: The real reason pot is still illegal)
On July 8th Washington became the second state after Colorado to offer recreational pot-smokers a chance to buy weed legally at a local store. Marijuana is still illegal in most of America. But there are substantial activities towards more liberal policies. In 23 states the medicinal use of marijuana is allowed and more states are considering legalisation. Oregon and Alaska will vote on legalisation in November; Floridians will decide on permitting medical use. President Barack Obama has chosen to take a hand’s-off approach to the issue of legalisation in Washington and Colorado. Yet if a drug hawk were to succeed President Obama in 2016, a clampdown on pot could well be revived.
The US Food and Drug Administration is reviewing the medical evidence surrounding the safety and effectiveness of marijuana, a process that could lead to the agency downgrading the drug's current status as a Schedule I drug, the most dangerous classification. "FDA conducts for Health and Human Services a scientific and medical analysis of the drug under consideration," FDA Press Officer Jeff Ventura said. "HHS then recommends to DEA that the drug be placed in a given schedule. DEA considers HHS’ analysis, conducts its own assessment, and makes a final scheduling proposal in the form of a proposed rule." (See also: Scheduling in the international drug control system)
Weed is legal in at least some form in 22 states and the District of Columbia. Most allow it for medical use only. Colorado and Washington this year enacted laws that allow recreational use by adults. But more than two dozen states are considering new or expanded marijuana reform legislation, including complete legalization for adults, medical marijuana, hemp use and decriminalization. Which are the next five states likely to legalize marijuana?
The GOP-controlled House voted in favor of blocking the federal government from interfering with states that permit the use of medical marijuana. The surprising 219-189 vote came as the House debated a bill funding the Justice Department's budget. The amendment by conservative GOP Rep. Dana Rohrabacher of California -- the first state to legalize medical marijuana -- came as almost half the states have legalized marijuana for medical uses. "Public opinion is shifting," Rohrabacher said, noting a recent Pew Research Center survey that found 61 percent of Republicans support medical marijuana. (See also: Is Congress finally catching on about medical marijuana?)
Una de las razones fundamentales por la que muchos Estados de Estados Unidos no han legalizado todavía la marihuana para su uso medicinal es por el temor a que hacerlo suponga un aumento de los delitos criminales. Pero un último estudio realizado por la universidad de Texas contradice esta creencia y ha concluido que legalizar la sustancia “no aumenta el número de crímenes e, incluso, reduce los homicidios”. La investigación, publicada en PLOS ONE, abre de nuevo el debate. La marihuana para usos medicinales fue aprobada por primera vez en EE UU en 1996.
A Colorado marijuana innovation is changing the way lawmakers in even the most conservative parts of the country talk about cannabis and is poised to create a rapid expansion in the number of states that have legalized marijuana in some way. But many marijuana advocates view the new political campaign with skepticism, fearing it could halt their movement's momentum. Taken to its logical conclusion, medical marijuana could be a "box canyon" for broader legalization efforts.
Los Angeles politicians have struggled for more than five years to regulate medical marijuana, trying to balance the needs of the sick against neighborhood concerns that pot shops attract crime. Voters will head to the polls to decide how Los Angeles should handle its high with three competing measures that seek to either limit the number of dispensaries or allow new ones to open and join an estimated several hundred others that currently operate.
The Drug Enforcement Administration sent cease-and-desist letters to 11 medical-marijuana dispensaries because they are within 1,000 feet of schools or other prohibited areas. The DEA maintains that the crackdown does not signal a federal war on Washington state’s new legal-pot law. Despite Washington state’s new legal recreational-pot law, enacted by voter-approved Initiative 502, all forms of marijuana remain illegal under federal law.
A bill introduced in Congress would fix the conflict between the federal government’s marijuana prohibition and state laws that allow medical or recreational use. California Republican Rep. Dana Rohrabacher said his bill, H.R. 1523, Respect State Marijuana Laws Act of 2013, which has three Republican and three Democratic sponsors, would assure that state laws on pot are respected by the feds. The measure would amend the Controlled Substances Act to make clear that individuals and businesses, including marijuana dispensaries, who comply with state marijuana laws are immune from federal prosecution.